$4.4 Billion Health Care Merger (CHSI, ESRX, SXCI)
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Catalyst shareholders will receive $28.00 in cash and 0.6606 shares of SXC stock for each Catalyst share, which implies a purchase price of $81.02 per Catalyst share and a premium of approximately 28% based on the closing stock prices of SXC and Catalyst on April 17, 2012 .
The deal is a response to last month’s $29 billion merger of Express Scripts Holdings Co. (NASDAQ: ESRX) and Medco Health. The combined market cap of SXC and Catalyst is $10 billion, a little more than a third of Express Scripts’ $28.5 billion market cap.
Shares of SXC are up about 9.8% at $88.10, which would be a new 52-week high if it holds. Shares of Catalyst are up almost 33% at $84.50, another 52-week high.
Paul Ausick
Contact [email protected] for any questions or corrections.
